SCHEMBL31589385

CC(C)(N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O

nearest known ligand 0.42

Predicted protein targets (top 11)

	gene	UniProt	supporting neighbours	confidence
▸	TLR2	O60603	1/20	0.42

▸	NPY4R	P50391	9/20	0.41

▸	NPY5R	Q15761	7/20	0.41

▸	NPY1R	P25929	6/20	0.41

▸	NPY2R	P49146	4/20	0.41

▸	SIRT5	Q9NXA8	1/20	0.40

▸	OPRM1	P35372	1/20	0.40

▸	NMT2	O60551	1/20	0.39

▸	NMT1	P30419	1/20	0.39

▸	SIRT6	Q8N6T7	1/20	0.38

▸	SIRT1	Q96EB6	1/20	0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30028687	0.85	NPY4R (0.52)	TLR2NPY4RNPY5RNPY1RNPY2R
SCHEMBL31589308	0.85	TLR2 (0.47)	TLR2NPY4RNPY5RNPY1RNPY2R
SCHEMBL31589811	0.85	TLR2 (0.47)	TLR2NPY4RNPY5RNPY1RNPY2R
SCHEMBL31590214	0.85	TLR2 (0.47)	TLR2NPY4RNPY5RNPY1RNPY2R
SCHEMBL31590045	0.85	TLR2 (0.47)	TLR2NPY4RNPY5RNPY1RNPY2R
SCHEMBL30787043	0.85	TLR2 (0.47)	TLR2NPY4RNPY5RNPY1RNPY2R
SCHEMBL31589616	0.85	TLR2 (0.47)	TLR2NPY4RNPY5RNPY1RNPY2R
SCHEMBL31589715	0.85	TLR2 (0.47)	TLR2NPY4RNPY5RNPY1RNPY2R
SCHEMBL31589766	0.85	TLR2 (0.47)	TLR2NPY4RNPY5RNPY1RNPY2R
SCHEMBL30029486	0.85	NPY4R (0.52)	TLR2NPY4RNPY5RNPY1RNPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
WO-2025106751-A1	COMBINATIONS OF A POTASSIUM CHANNEL ACTIVATOR AND AN MC4R AGONIST AND RELATED METHODS OF USE	RHYTHM PHARMACEUTICALS, INC. (US)	2025-05-22	—	—	WO	disclosed